Germany is one of the most important and developed healthcare markets in the world. Legal developments are complex and often connected, whether in the areas of advanced therapies, digital health solutions, supply chain management, licensing transactions/collaborations/M&A, or COVID-19, to name a few. Partners Andreas von Falk, Martin Pflüger, Jörg Schickert and Matthias Schweiger share their insights on the trends and developments for the German market in the latest Chambers Life Sciences 2022 guide.
Read the full chapter on trends and developments in the German market in the Chambers Life Sciences 2022 Guide here.
Authored by Andreas von Falk, Martin Pflüger, Jörg Schickert and Matthias Schweiger.
Are you sure want to delete comment ?
Scan this QR Code to share this content
